Literature DB >> 17001605

Proteomics for the analysis of the Candida albicans biofilm lifestyle.

Derek P Thomas1, Stefano P Bachmann, Jose L Lopez-Ribot.   

Abstract

Candida albicans is an opportunistic pathogenic fungus capable of causing infections in immunocompromised patients. Candidiasis is often associated with the formation of biofilms on the surface of inert or biological materials. Biofilms are structured microbial communities attached to a surface and encased within a matrix of exopolymeric substance (EPS). At present, very little is known about the changes in protein profiles that occur during the transition from the planktonic to the biofilm mode of growth. Here, we report the use of proteomics for the comparative analysis of subcellular fractions obtained from C. albicans biofilm and planktonic cultures, including cell surface-associated proteins and secreted components present in liquid culture supernatants (for planktonic cultures) and EPS (for biofilms). The analysis revealed a high degree of similarity between the protein profiles associated with the planktonic and biofilm extracts, and led to the identification of several differentially expressed protein spots. Among the differentially expressed proteins, there was a preponderance of metabolic enzymes that have been described as cell surface proteins and immunodominant antigens. Proteins found in the biofilm matrix included a few predicted to form part of the secretome, and also many secretion-signal-less proteins. These observations contribute to our understanding of the C. albicans biofilm lifestyle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001605     DOI: 10.1002/pmic.200600332

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  45 in total

1.  Proteolytic cleavage of covalently linked cell wall proteins by Candida albicans Sap9 and Sap10.

Authors:  Lydia Schild; Antje Heyken; Piet W J de Groot; Ekkehard Hiller; Marlen Mock; Chris de Koster; Uwe Horn; Steffen Rupp; Bernhard Hube
Journal:  Eukaryot Cell       Date:  2010-11-19

Review 2.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

Review 3.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

4.  Identification of biofilm matrix-associated proteins from an acid mine drainage microbial community.

Authors:  Yongqin Jiao; Patrik D'haeseleer; Brian D Dill; Manesh Shah; Nathan C Verberkmoes; Robert L Hettich; Jillian F Banfield; Michael P Thelen
Journal:  Appl Environ Microbiol       Date:  2011-06-17       Impact factor: 4.792

5.  Large-scale production and isolation of Candida biofilm extracellular matrix.

Authors:  Robert Zarnowski; Hiram Sanchez; David R Andes
Journal:  Nat Protoc       Date:  2016-10-27       Impact factor: 13.491

6.  Candida albicans Biofilm Development and Its Genetic Control.

Authors:  Jigar V Desai; Aaron P Mitchell
Journal:  Microbiol Spectr       Date:  2015-06

Review 7.  Fungal biofilms, drug resistance, and recurrent infection.

Authors:  Jigar V Desai; Aaron P Mitchell; David R Andes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

Review 8.  Plasticity of Candida albicans Biofilms.

Authors:  David R Soll; Karla J Daniels
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-01       Impact factor: 11.056

9.  Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms.

Authors:  Margarida Martins; Priya Uppuluri; Derek P Thomas; Ian A Cleary; Mariana Henriques; José L Lopez-Ribot; Rosário Oliveira
Journal:  Mycopathologia       Date:  2009-12-13       Impact factor: 2.574

10.  Effect of tunicamycin on Candida albicans biofilm formation and maintenance.

Authors:  Christopher G Pierce; Derek P Thomas; José L López-Ribot
Journal:  J Antimicrob Chemother       Date:  2008-12-20       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.